Oppenheimer & Co’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.71M Sell
3,841
-2,360
-38% -$1.05M 0.02% 628
2025
Q1
$3.01M Sell
6,201
-1,428
-19% -$692K 0.05% 427
2024
Q4
$3.07M Sell
7,629
-5,499
-42% -$2.21M 0.05% 422
2024
Q3
$6.11M Sell
13,128
-601
-4% -$280K 0.09% 239
2024
Q2
$6.44M Buy
13,729
+1,099
+9% +$515K 0.1% 220
2024
Q1
$5.28M Buy
12,630
+754
+6% +$315K 0.09% 260
2023
Q4
$4.83M Buy
11,876
+1,568
+15% +$638K 0.09% 261
2023
Q3
$3.58M Buy
10,308
+1,797
+21% +$625K 0.07% 302
2023
Q2
$3M Buy
8,511
+675
+9% +$238K 0.06% 368
2023
Q1
$2.47M Sell
7,836
-7,563
-49% -$2.38M 0.05% 395
2022
Q4
$4.45M Sell
15,399
-1,088
-7% -$314K 0.1% 245
2022
Q3
$4.77M Buy
16,487
+945
+6% +$274K 0.11% 225
2022
Q2
$4.38M Buy
15,542
+972
+7% +$274K 0.09% 255
2022
Q1
$3.8M Buy
14,570
+6,805
+88% +$1.78M 0.07% 339
2021
Q4
$1.71M Buy
7,765
+4,340
+127% +$953K 0.03% 563
2021
Q3
$621K Buy
3,425
+1,344
+65% +$244K 0.01% 928
2021
Q2
$420K Sell
2,081
-2,954
-59% -$596K 0.01% 1108
2021
Q1
$1.08M Sell
5,035
-2,332
-32% -$501K 0.02% 680
2020
Q4
$1.74M Buy
7,367
+2,375
+48% +$561K 0.04% 480
2020
Q3
$1.36M Sell
4,992
-3,712
-43% -$1.01M 0.03% 480
2020
Q2
$2.53M Buy
8,704
+903
+12% +$262K 0.07% 320
2020
Q1
$1.86M Buy
7,801
+2,313
+42% +$550K 0.06% 356
2019
Q4
$1.2M Sell
5,488
-64
-1% -$14K 0.03% 561
2019
Q3
$941K Buy
5,552
+826
+17% +$140K 0.03% 616
2019
Q2
$867K Sell
4,726
-1,774
-27% -$325K 0.02% 637
2019
Q1
$1.2M Sell
6,500
-1,315
-17% -$242K 0.03% 537
2018
Q4
$1.3M Sell
7,815
-3,687
-32% -$611K 0.04% 446
2018
Q3
$2.22M Buy
11,502
+3,302
+40% +$636K 0.06% 372
2018
Q2
$1.39M Sell
8,200
-1,090
-12% -$185K 0.04% 484
2018
Q1
$1.51M Buy
9,290
+4,131
+80% +$673K 0.04% 471
2017
Q4
$773K Buy
5,159
+714
+16% +$107K 0.02% 699
2017
Q3
$676K Buy
+4,445
New +$676K 0.02% 741